CYTEK BIOSCIENCES, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
CYTEK BIOSCIENCES, INC. (CTKB) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $4.22 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $4.23, a 1.86% decline year-over-year.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $4.31, a 39.04% decline year-over-year.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $7.07, a 32.60% decline year-over-year.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $10.49, a 23.09% decline year-over-year.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $4.25, a 38.05% decline from fiscal 2024.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $6.86, a 32.01% decline from fiscal 2023.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $10.09, a 18.83% decline from fiscal 2022.
- CYTEK BIOSCIENCES, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $12.43, a 4.31% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.22 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | $4.23 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $4.25 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $4.24 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | $4.24 10-Q · filed 2025-08-06 | |||
| 2025-03-31 | $4.31 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | $6.86 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $6.86 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $6.86 10-Q · filed 2024-08-06 | |||
| 2024-03-31 | $7.07 10-Q · filed 2024-05-08 | |||
| 2023-12-31 | $10.09 10-K · filed 2025-02-28 | |||
| 2023-09-30 | $10.09 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $10.23 10-Q · filed 2023-08-08 | |||
| 2023-03-31 | $10.49 10-Q · filed 2023-05-09 | |||
| 2022-12-31 | $12.43 10-K · filed 2024-03-13 | |||
| 2022-09-30 | $12.32 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | $12.32 10-Q · filed 2022-08-10 | |||
| 2022-03-31 | $13.64 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $12.99 10-K · filed 2023-03-01 | |||
| 2021-09-30 | $12.97 10-Q · filed 2021-11-12 | |||
| 2021-06-30 | $5.06 10-Q · filed 2021-09-03 | |||
| 2020-12-31 | $1.37 10-K · filed 2022-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |